Zosano Pharma Revenue and Competitors

Location

$242.6M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Zosano Pharma's estimated annual revenue is currently $7.5M per year.(i)
  • Zosano Pharma's estimated revenue per employee is $156,250
  • Zosano Pharma's total funding is $242.6M.

Employee Data

  • Zosano Pharma has 48 Employees.(i)
  • Zosano Pharma grew their employee count by 0% last year.

Zosano Pharma's People

NameTitleEmail/Phone
1
VP Technical OperationsReveal Email/Phone
2
VP, Clinical Development and Medical AffairsReveal Email/Phone
3
VP, Quality Assurance & Regulatory AffairsReveal Email/Phone
4
VP & Corporate ContollerReveal Email/Phone
5
VP Research & DevelopmentReveal Email/Phone
6
Chief Financial OfficerReveal Email/Phone
7
Manager, Process DevelopmentReveal Email/Phone
8
ManagerReveal Email/Phone
9
Senior Manager Equipment Engineering and GMP FacilitiesReveal Email/Phone
10
Mfg. Associate IIIReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$84.8M42224%N/AN/A
#2
$0.4M20%N/AN/A
#3
$32M1593%N/AN/A
#4
$35M1213%$62.5MN/A
#5
$30.2M15018%N/AN/A
#6
$135.3M6730%N/AN/A
#7
$110.3M549N/AN/AN/A
#8
$60.1M299-4%N/AN/A
#9
$554.8M17252%N/AN/A
#10
$10.5M524%N/AN/A
Add Company

What Is Zosano Pharma?

Zosano Pharma ™, Inc., formerly named The Macroflux Corporation, is private specialty pharmaceutical company creating better products utilizing innovative drug delivery technology. Zosano’s transdermal microprojection delivery system provides unique benefits including convenient needle-free administration with room temperature stability for various peptides, proteins, small molecules, biopharmaceuticals and vaccines.

keywords:Biotechnology

$242.6M

Total Funding

48

Number of Employees

$7.5M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Zosano Pharma News

2022-04-19 - Zosano Pharma Co. (NASDAQ:ZSAN) Short Interest Update

Get Zosano Pharma alerts: A number of hedge funds and other institutional investors have recently modified their holdings of ZSAN. Morgan...

2022-04-06 - Zosano Pharma Announces Reverse Stock Split Effective Today

FREMONT, Calif., April 11, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company,...

2022-04-06 - Is Zosano Pharma (ZSAN) Stock Really Up 3,000% Today?

In pre-market trading, the share price of Zosano Pharma (NASDAQ:ZSAN) stock is incredibly soaring nearly 3,000%. But the total value of all...

2007-11-15 - Life sciences briefing: Thursday, Nov. 15, 2007

Featured companies: BioVex, FullTurn Media, Humanetics, N Spine, Novitas Capital, Reliant Technologies, Symbios, Vaxart, Virtual Radiologic, Winston Laboratories, Zosano Pharma EXPANDING ITEMS: Stay tuned. Vaxart receives $3.3M for oral vaccines — San Francisco’s Vaxart, a biotech developing n ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.6M48-11%N/A
#2
$10.4M487%N/A
#3
$5.6M4841%N/A
#4
$6.9M48-8%N/A
#5
$12M484%N/A